News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Canada Bans Pfizer Inc. Arthritis Drug Bextra; Will Not Return To Market
December 16, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
OTTAWA, Dec 16 (Reuters) - Canada banned Pfizer Inc.'s (PFE.N: Quote, Profile, Research) arthritis drug Bextra on Friday because of risks of heart attacks and strokes.
Twitter
LinkedIn
Facebook
Email
Print
Pfizer
